The differences in highly regulable VTN mRNA levels in cultured hepatocytes by cholinergic receptor activation and the very stable mRNA levels in the female mice after stroke or bethanechol treatment suggest that other mechanisms, including the cellular environment, regulate VTN mRNA expression in vivo (Jia, Malone, et al., 2020). The gene discussed is VTN; the disease is stroke disorder.